Precision nanomedicine: Shaping cellulose nanocrystals
The invention consists of a smart, inexpensive and biocompatible nanomaterial with custom-designed bioactivity.
The invention consists of a smart, inexpensive and biocompatible nanomaterial with custom-designed bioactivity.
The patent application protects nontoxic small molecules (glycomimetics), easily obtained from natural compounds (carbohydrates), which can be used for personalized treatment of glycan-related diseases
The invention relates to a 'Clustered Regularly Interspersed Short Palindromic Repeat (CRISPR) CRISPR associated (Cas)’ (CRISPR-Cas) system targeting a genome sequence in a eukaryotic cell, i.e. a system useful for making modifications within the cell genome.
The method proposed is designed to produce individualized face masks that are well tolerated by small patients
The invention refers to the use of an engineered 'Clustered Regularly Interspersed Short Palindromic Repeat (CRISPR)-CRISPR associated (Cas)’ (CRISPR-Cas) technology targeting a sequence mutated at one or more loci in the genome of a given eukaryotic cell